Exposure–Response Modeling Predicted Long-Lasting Responses with Lebrikizumab Every 8 Week Maintenance Dosing for Moderate-to-Severe Atopic Dermatitis and Aligned with Observed Clinical Trial Data

Authors

• April Armstrong
• Andrew Blauvelt
• Alan Irvine
• Peter Lio
• Linda Stein Gold, Henry Ford HealthFollow
• Gaia Gallo
• Yuxin Ding
• Hany Elmaraghy
• Brian Moser
• Emma Guttman-Yassky

Recommended Citation

Armstrong A, Blauvelt A, Irvine A, Lio P, Stein Gold L, Gallo G, Ding Y, Elmaraghy H, Moser B, Guttman-Yassky E. Exposure–Response Modeling Predicted Long-Lasting Responses with Lebrikizumab Every 8 Week Maintenance Dosing for Moderate-to-Severe Atopic Dermatitis and Aligned with Observed Clinical Trial Data. J Am Acad Dermatol 2026; 95(1):AB222.

Document Type

Conference Proceeding

Publication Date

7-1-2026

Publication Title

J Am Acad Dermatol

Volume

95

Issue

1

First Page

AB222